🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us Society for Immunotherapy of Cancer Spring Scientific on #CellularTherapy for #SolidTumors in San Diego, March 12-14. Session preview: "Novel Targets for Solid Tumor Cell Therapies" featuring experts Drs. Heath Lab, Hideho Okada & Mark Yarmarkovich. Program and registration: sitcancer.org/education/spri…

Join us Society for Immunotherapy of Cancer Spring Scientific on #CellularTherapy for #SolidTumors in San Diego, March 12-14. Session preview: "CARs for Solid Cancers" featuring experts Drs. Chrystal Mackall, Daniel Powell Lab @ UPENN and Christina Puig-Saus. Program and registration: sitcancer.org/education/spri…

#FDA and #NIH employees are driven by the mission of their offices and Institutes— not the money (considerably higher salaries await in the private sector), not the status, not the so-called desire to waste taxpayer dollars. HHS Job Cuts Jeopardize Our Health and Safety

The Founders of the U.S. left us explicit instructions. 🧵👇 details the threats "There is nothing which can better deserve your patronage, than the promotion of science and literature. Knowledge is in every country the surest basis of public happiness.” — George Washington's

EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models Cancer Cell Marco Ruella cell.com/cancer-cell/fu…

Exciting news: EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models Cancer Cell Marco Ruella Alberto Carturan Puneeth Guruprasad Ruchi Patel Yunlin Zhang Guido Ghilardi and my stellar co-author Siena Nason cell.com/cancer-cell/ab…

Marco Ruella

Porazzi and Nason et al. showed that EZH2 inhibition sensitizes a broad spectrum of tumors to diverse adoptive T cell immunotherapies. bit.ly/41x6cFS  Marco Ruella

👉👉 Amazing Keynote talk by Dr Marco Ruella Marco Ruella to mark the start of 2-day CAR T and Bispecific focus meeting Noopur Raje Dr Sattva Neelapu

Excited to be part of the 2025 Society for Immunotherapy of Cancer Sparkathon! Thanks to Marco Ruella for the kind invitation 🙏

Dear Trainees, bookmark this👇 Dr. Marco Ruella Society for Immunotherapy of Cancer teaching us how to give a good talk, by purposefully giving a *bad* talk! 👏😉 - Lighter the better - Less is more - Consistent font - Large font size (>=18) - Careful with animations: friends sometimes (to help introduce

Inhibiting EZH1/2 increases the efficacy of CAR-T and TCR-T cells in preclinical models of both liquid and solid cancers. Kudos to Marco Ruella & team! cell.com/cancer-cell/fu…

And the 2025 Society for Immunotherapy of Cancer #Sparkathon has come to a close! Many thanks to Jennifer Guerriero, PhD Marco Ruella and the @sitccancer team for the fantastic organization. Congrats to all "Sparkies" for the top-notch science and great presentations. The future of immunotherapy is bright my

SITC would like to extend our gratitude towards the Sparkathon Class of 2025! It was a successful program on Cellular Therapy for Solid Tumors. We look forward to meeting again @ SITC's 40th Anniversary Annual Meeting & Pre-Conference Programs! #Sparkathon sitcancer.org/2025

It is truly the highlight of my career to organize the Society for Immunotherapy of Cancer Sparkathon mentoring program for early career scientists and physicians together with Marco Ruella. This class of Spakies is incredible and inspiring. The future of medicine and science is so bright. ✨

Happy CD3 CD28 T Cell Stimulation Day to all who celebrate #TCell #immunology

New research out in Cancer Cell finds that EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models ft. Patrizia Porazzi, Siena Nason & Marco Ruella (Penn Medicine - Abramson Cancer Center) Ruella Lab cell.com/cancer-cell/fu…

New #JITC article: CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy bit.ly/3EDIVJu Marco Ruella @gruppsteve Regina Myers Caroline Diorio

The human toll of these cuts — the thousands of personal tragedies playing out across the country, far beyond the NIH’s Maryland campus — is incalculable, but these five stories illustrate the trauma that people are weathering as labs go dark, careers evaporate overnight, and

Join Session Chairperson and CRI CLIP Investigator Marco Ruella of Penn Medicine at 8 AM for ED22 - CAR-T Cells in Hematological Malignancies: Innovations and Pitfalls, and for his talk during the session! More info from AACR: bit.ly/4lMem5c #AACR25 #CancerResearch